<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR99">
 <label>99.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Borzilleri</surname>
    <given-names>RM</given-names>
   </name>
   <name>
    <surname>Bhide</surname>
    <given-names>RS</given-names>
   </name>
   <name>
    <surname>Barrish</surname>
    <given-names>JC</given-names>
   </name>
   <name>
    <surname>Dâ€™Arienzo</surname>
    <given-names>CJ</given-names>
   </name>
   <name>
    <surname>Derbin</surname>
    <given-names>GM</given-names>
   </name>
   <name>
    <surname>Fargnoli</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Discovery and evaluation of N-cyclopropyl-2, 4-difluoro-5-((2-(pyridin-2-ylamino) thiazol-5-ylmethyl) amino) benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2</article-title>
  <source>J Medicinal Chem</source>
  <year>2006</year>
  <volume>49</volume>
  <fpage>3766</fpage>
  <lpage>9</lpage>
  <pub-id pub-id-type="doi">10.1021/jm060347y</pub-id>
 </element-citation>
</ref>
